The Big Breakthrough?

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

 http://www.ncbi.nlm.nih.gov/pubmed/24964991

Popular Post in the Last 30 Days

Popular Posts from the Last Year

All Time Most Popular Posts